Inactive Instrument

Insiders Lansen Pharmaceutical Holdings Limited

Equities

503 KYG5380M1033

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

Lansen Pharmaceutical Holdings Limited Appoints Zhu Xun as Independent Non-Executive Director and Member of the Remuneration Committee	22-09-23	CI
Lansen Pharmaceutical Holdings Limited Approves to Elect Chan Ching Har, Eliza as an Independent Non-Executive Director	22-06-23	CI
Lansen Pharmaceutical Holdings Limited Announces Resignation of Stephen Burnau Hunt as Non-Executive Director and Member of the Remuneration Committee	22-04-11	CI
Lansen Pharmaceutical Holdings Limited Announces Establishment of Nomination Committee and Appointment of Chairman and Members of the Nomination Committee	22-03-23	CI
Lansen Pharmaceutical Holdings Limited Announces Executive Changes	22-02-10	CI
Lansen Pharmaceutical Holdings Limited Announces Resignation of Lee Jin Yi as an Non Executive Director and Member of the Remuneration Committee, the Member of the Audit Committee and Vice Chairman of the Executive Committee	19-10-31	CI
Lansen Pharmaceutical Holdings Limited Announces Management Changes, Effective 13 June 2019	19-06-12	CI
Lansen Pharmaceutical Holdings Limited Announces Board Changes	19-04-08	CI
Lansen Pharmaceutical Holdings Limited Announces the Resignation of Hou Song as Director and Chief Financial Officer, with Effect from October 20, 2018	18-10-12	CI
Lansen Pharmaceutical Holdings Limited Appoints Yeung Tak Bun as an Independent Non-Executive Director, Member of Audit Committee and Member of Remuneration Committee, Effective October 6, 2018	18-09-26	CI
Lansen Pharmaceutical Holdings Limited Announces Company Secretary Changes, Effective from June 22, 2018	18-06-15	CI
Lansen Pharmaceutical Holdings Limited Appoints Chen Li as Executive Managing Director, Member of the Executive Committee and the Chief Executive Officer with Effect from 1 March 2018	18-02-09	CI
Lansen Pharmaceutical Holdings Limited Announces Executive Changes	18-01-29	CI
Lansen Pharmaceutical Holdings Limited Announces Board Changes, Effective 30 March, 2017	17-03-30	CI
Lansen Pharmaceutical Holdings Limited Appoints Ms. Liu Xuezi and Ms. Tao Fang Fang as Members of Executive Committee	16-12-16	CI
Lansen Pharmaceutical Holdings Limited Announces Board Changes	16-03-30	CI
Lansen Pharmaceutical Holdings Limited Appoints Hou Song as Chief Financial Officer, Effective from 16 September 2015	15-09-10	CI
Lansen Pharmaceutical Holdings Limited Announces Executive Changes	15-09-04	CI
Lansen group Announces Executive Changes	13-03-06	CI
Lansen Pharmaceutical Holdings Co., Ltd Announces Board Changes	13-03-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Lansen Pharmaceutical Holdings Limited

Equities

503

KYG5380M1033

Insiders

Filters